Page 2 of GSK

GSK, otilimab, investigational monoclonal antibody, Rheumatoid Arthritis (RA), Health news, pharma news,

GSK India appoints Bhushan Akshikar as new Managing Director

Akshikar replaces Sridhar Venkatesh, who is moving to a new senior role within GSK Group effective December 1, 2022, the…

October 17, 2022 17:08 IST

GSK, RSV, RSV vaccine, health news, pharma news,

GSK’s RSV vaccine over 82 percent effective, Late-stage study data reveals

In June, the trial had yielded statistically significant results for the shot, but on Thursday gave details about the performance…

October 13, 2022 14:03 IST

GSK, Spero Therapeutics, Urinary tract infection, health news, pharma news,

GSK takes stake in Spero Therapeutics for its experimental urinary tract infection drug

Reportedly, Spero’s shares closed down 6.7% at 82 cents on Wednesday, while GSK was marginally down in early trade on…

September 22, 2022 18:04 IST

GSK, myelofibrosis, USFDA, Momelotinib, Health news, pharma news,

USFDA accepts GSK’s NDA for momelotinib to treat myelofibrosis

Myelofibrosis is a rare blood cancer that results from dysregulated JAK-signal transducer and activator of transcription protein signalling and is…

August 19, 2022 11:33 IST

GSK, Sanofi, Haleon, Pfizer, health news, pharma news, shares, share market,

After Zantac litigation dip, shares of drugmakers stabilise

Zantac, originally marketed by a forerunner of GSK, has been sold by several companies since the loss of patent exclusivity…

August 12, 2022 18:21 IST

GSK, Sanofi, Haleon, shares, stock market, zantac, health news, pharma news,

Shares of GSK, Sanofi and Haleon decline amid Zantac litigation concerns

The drug was marketed by GSK between 1995 and 1998, by Pfizer from 2000 to 2006, by Johnson & Johnson…

August 11, 2022 20:32 IST

GSK signs contract with European Commission’s HERA to supply 85 million doses of Adjupanrix

Reportedly, this agreement with HERA concludes a series of contracts secured by GSK this year, under which it could provide…

July 29, 2022 17:21 IST

GSK, vaccines, health news, pharma news,

GSK gathers global experts to discuss role of vaccines in protecting people and the planet

Meanwhile, speakers at this year’s event include Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at…

July 8, 2022 19:35 IST

GSK launches single-inhaler triple therapy in India for COPD patients

Estimated COPD prevalence in India is over 100 million and accounts for over 9.5% of the total deaths in India.

April 26, 2022 17:41 IST

Related News

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zukerberg to lead Meta superintelligence labs

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zuckerberg to lead Meta superintelligence labs

e-Passport launched in India: Who can apply, how to apply, application fee, benefits, key security upgrades and more

Canada work permit, Canada Temporary Foreign Worker Program, Canada TFWP Rules, Canada LMIA process, LMIA process

Canada drops wage assessment under TFWP; Work permits now based on LMIA

US Cancels 85,000 Visas This Year, Including 8,000 Student Permits

US revokes 8,000 student visas in immigration crackdown; overall cancellations hit 85,000

H-1B visas, US Visa, F-1 visa, Indian students in US, Indian workers in US, Ministry of External Affairs

US tightens F-1 and H-1B visa rules; questions raised in parliament: MEA responds

PFC, SIDBI scrap bond issuances amid higher yields

Business6 hr ago

PFC and SIDBI have scrapped bond issuances worth Rs 11,500 crore due to rising yields, despite a recent rate cut by the RBI. PFC’s planned issuance of Rs 3,500 crore would have had a cut-off yield of 7.17%, higher than expected. SIDBI’s fundraising plans of Rs 8,000 crore also faced difficulties, with a cut-off yield of 6.86% instead of the desired 6.75%. Dealers express uncertainty

View all shorts